Sema: The GP-1 Agonist Research Profile

Peptide Profiles — 2026-04-13

Sema is a long-acting glucagon-like peptide-1 (GP-1) receptor agonist that has transformed metabolic research. Extensively studied in phase 3 clinical trials, it has set the modern benchmark for single-receptor metabolic peptides.

Mechanism of Action

Sema is a GP-1 analog engineered for extended half-life. Structural modifications — including albumin-binding fatty acid chains — give it a half-life of approximately one week, enabling weekly administration protocols in research.

At the molecular level, sema acts as a selective agonist at the GP-1 receptor, triggering: - Glucose-dependent insulin secretion - Suppression of glucagon release - Delayed gastric emptying - Central appetite suppression signals

Studied Benefits

Weight Reduction In the STEP clinical trial program, sema demonstrated: - Average weight reductions of 15-17% at higher doses - Sustained effect over 68+ week studies - Dose-dependent response - Benefits preserved across diverse populations

Glucose Control Sema's primary research application remains glycemic regulation: - Substantial HbA1c reductions - Glucose-dependent mechanism reduces hypoglycemia risk - Beta cell function preservation research ongoing

Cardiovascular Research Long-term cardiovascular outcome trials (SUSTAIN-6, SELECT) have reported: - Reductions in major adverse cardiovascular events - Favorable effects on blood pressure - Improvements in lipid markers

Emerging Research Areas - Kidney function and chronic kidney disease - Hepatic steatosis (NAFLD/MASH) studies - Neurodegenerative disease preclinical research - Inflammation and cardiometabolic markers

Research Considerations

Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.

Shop Research Peptides